latest news releases from the newsroom
FTS Wireless, Inc.
FTS Breaks Company Sales Record
TAMPA, Fla., Jan. 30, 2006 (PRIMEZONE) -- FTS Group, Inc. (OTCBB:FLIP), a publicly traded acquisition and development Company operating in the wireless space through its wholly owned subsidiaries FTS Wireless, Inc. and See World Satellites, Inc., today announced that FTS Wireless has again set a Company record for monthly wireless handset sales during January.
OTCPicks.com Announces Initiation of Profile Coverage for Caneum, Inc.
PROSPER, Texas, Jan. 30, 2006 (PRIMEZONE) -- Brian Dean, Publisher of OTCPicks.com, announced today that the website has initiated profile coverage of Caneum, Inc. (OTCBB:CANM). Says Mr. Dean, "Some the investment highlights for Caneum, Inc. include a company with less than 5M shares outstanding, a management team that has sold 3 companies for $200M over the past 5 years to household names such as Cisco Systems, Internet Security Systems and Level 3 Communications, no debt on the books, an estimated $1 trillion per year outsourcing market opportunity by 2010, and 10 quarters of corporate sequential revenue growth with a CAGR above 70% quarter over quarter during the last two and a half years. We believe that at current price levels, CANM represents a good investment value relative to other companies and stocks in the Business Process Outsourcing (BPO) market."
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals to Present at the Brean Murray, Carret Small Cap Institutional Investor Conference
NEW YORK, Jan. 30, 2006 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the Company, including the KRX-101 (sulodexide) Phase II data and the ongoing Phase III/IV clinical program, at The Brean Murray, Carret Small Cap Institutional Investor Conference in New York City. Mr. Weiss' presentation will take place on Wednesday, February 1, 2006, at 10:00 a.m. Eastern Time at the Grand Hyatt New York Hotel. A live audio webcast of Mr. Weiss' presentation will be available at http://www.wsw.com/webcast/bmry2/kerx/. An archived version of the webcast will be available following the conclusion of the live presentation.
QLogic Executives to Present at Thomas Weisel Partners Technology Conference
ALISO VIEJO, Calif., Jan. 30, 2006 (PRIMEZONE) -- QLogic Corp. (Nasdaq:QLGC), the leader in Fibre Channel host bus adapters (HBAs), stackable switches and blade server switches, today announced that H.K. Desai, chairman, CEO and president, and Tony Massetti, senior vice president and CFO, will present at the Thomas Weisel Partners 2006 Technology Conference on Tuesday, Feb. 7 at 9:45 a.m. Pacific Time in San Francisco. The conference will be held at the Fairmont Hotel.
ReelTime Rentals Chairman Attends NATPE 2006 Conference
SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- ReelTime Rentals, Inc. (Pink Sheets:RLTR) announces that the Company's Chairman, Barry Henthorn, attended the NATPE 2006 Conference held at Mandalay Bay Resort in Las Vegas on January 24-26, 2006. The National Association of Television Producers (NATPE) is a global, non-profit organization dedicated to the creation, development and distribution of televised programming in all forms across all mature and emerging media platforms.
Eagle Bulk Shipping
Eagle Bulk Shipping, Inc. Declares Dividend
NEW YORK, Jan. 30, 2006 (PRIMEZONE) -- Eagle Bulk Shipping Inc. (Nasdaq:EGLE) today announced that its Board of Directors has voted to declare a cash dividend on its common stock for the fourth quarter of 2005 of $0.57 per share payable on or about February 24, 2006, to all shareholders of record as at February 15, 2006.
Cytomedix Submits Application to FDA Seeking Marketing Clearance of Its AutoloGel System
ROCKVILLE, Md., Jan. 30, 2006 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF), a biotechnology company specializing in the research, development, licensing, and systems for treating non-healing chronic wounds including diabetic ulcers, today announced that the Company has submitted a premarket 510(k) application to the U.S. Food and Drug Administration (FDA) seeking clearance of its AutoloGel(tm) System for specific wound healing indications, based on the results of its diabetic foot ulcer clinical trial and other available data.